Tuberous Sclerosis Complex (TSC) is characterized by the multiorgan development of benign tumors and is related to lymphangioleiomyomatosis (LAM), a rare disease caused by abnormal growth of smooth muscle (ASM) cells within lung parenchyma and axial lymphatics. From an angiomyolipoma of a TSC2 patient and from chylous of a TSC-associated LAM patient, TSC2-/- ASM and LAM/TSC cells, respectively, have been isolated. Proliferation depends on epidermal growth factor (EGF) and antibodies to EGF receptor (anti-EGFR) caused cell death. We developed animal models by endonasal administration of TSC2-/- ASM or LAM/TSC cells in immunodeficient female athymic nude mice. Both cells were infiltrated into pulmonary alveolar walls where they caused enlarged alveolar spaces. Only LAM/TSC cell administration was associated to nodules development in lung parenchyma in 30 weeks. Pulmonary nodules arose in 46% of LAM/TSC cell administrated mice. This percentage significantly decreased after anti-EGFR (25%) or rapamycin (33%) treatments. Pulmonary nodules were localized near lymphatic and blood vessels or bronchioli and showed positivity to phospho-S6, and estrogen and progesterone receptors. Within the nodules we identified human LAM/TSC cells. In conclusion, LAM/TSC cells, but not TSC2-/- ASM cells, caused pulmonary nodule formation. Rapamycin and more significantly anti-EGFR antibody reduced the number of pulmonary metastases.
LAM/TSC cells cause pulmonary nodule development by endonasal administration in nude mice / E. Chiaramonte, C. Bernardelli, S. Ancona, E. Orpianesi, E. Lesma, A.M. Di Giulio, A. Gorio. ((Intervento presentato al convegno International TSC Congress tenutosi a Napoli nel 2012.
LAM/TSC cells cause pulmonary nodule development by endonasal administration in nude mice
C. Bernardelli;S. Ancona;E. Orpianesi;E. Lesma;A.M. Di GiulioPenultimo
;A. GorioUltimo
2012
Abstract
Tuberous Sclerosis Complex (TSC) is characterized by the multiorgan development of benign tumors and is related to lymphangioleiomyomatosis (LAM), a rare disease caused by abnormal growth of smooth muscle (ASM) cells within lung parenchyma and axial lymphatics. From an angiomyolipoma of a TSC2 patient and from chylous of a TSC-associated LAM patient, TSC2-/- ASM and LAM/TSC cells, respectively, have been isolated. Proliferation depends on epidermal growth factor (EGF) and antibodies to EGF receptor (anti-EGFR) caused cell death. We developed animal models by endonasal administration of TSC2-/- ASM or LAM/TSC cells in immunodeficient female athymic nude mice. Both cells were infiltrated into pulmonary alveolar walls where they caused enlarged alveolar spaces. Only LAM/TSC cell administration was associated to nodules development in lung parenchyma in 30 weeks. Pulmonary nodules arose in 46% of LAM/TSC cell administrated mice. This percentage significantly decreased after anti-EGFR (25%) or rapamycin (33%) treatments. Pulmonary nodules were localized near lymphatic and blood vessels or bronchioli and showed positivity to phospho-S6, and estrogen and progesterone receptors. Within the nodules we identified human LAM/TSC cells. In conclusion, LAM/TSC cells, but not TSC2-/- ASM cells, caused pulmonary nodule formation. Rapamycin and more significantly anti-EGFR antibody reduced the number of pulmonary metastases.Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.